Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :2431
Small font sizeDefault font sizeIncrease font size
Navigate here
Resource links
   Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
   Article in PDF (1,101 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

  In this article
   Article Figures

 Article Access Statistics
    PDF Downloaded167    
    Comments [Add]    
    Cited by others 1    

Recommend this journal


  Table of Contents  
Year : 2015  |  Volume : 52  |  Issue : 4  |  Page : 688-689

Intrascrotal paratesticular malignant fibrous histiocytoma-a rare case and its management

1 Department of Surgical Oncology, All India Institute of Medical Science, New Delhi, India
2 Department of Pathology, All India Institute of Medical Science, New Delhi, India

Date of Web Publication10-Mar-2016

Correspondence Address:
A A Kallianpur
Department of Surgical Oncology, All India Institute of Medical Science, New Delhi
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0019-509X.178381

Rights and Permissions

How to cite this article:
Kallianpur A A, Kapali A, Shukla N K, Deo S, Muduly D, Yadav R. Intrascrotal paratesticular malignant fibrous histiocytoma-a rare case and its management. Indian J Cancer 2015;52:688-9

How to cite this URL:
Kallianpur A A, Kapali A, Shukla N K, Deo S, Muduly D, Yadav R. Intrascrotal paratesticular malignant fibrous histiocytoma-a rare case and its management. Indian J Cancer [serial online] 2015 [cited 2021 Aug 5];52:688-9. Available from: https://www.indianjcancer.com/text.asp?2015/52/4/688/178381


Paratesticular malignant fibrous histiocytoma (MFH) is an extremely rare malignancy of the scrotum, and scant information exists on the optimal management of this cancer.

We report a case of 71 year old male who presented with two months history of right testicular lump. In an outside hospital patient underwent right transcrotal orchidectomy in April 2009. Histopathology findings of the specimen were compatible with malignant mesenchymal tumor. Slides and blocks were reviewed in our hospital and revealed same morphology as the main specimen. Patient received six cycles of adriamycin and cyclophosphamide based adjuvant chemotherapy. Patient was disease free for 21 months before he developed local recurrence. On local examination there was a 10 × 8 cm lobulated mass at the right inguinal region involving the left testis with no overlying skin involvement. Contrast enhanced computerized tomography confirmed an 10 cm heterogenous enhanced mass at the root of penis and separate mass at the left testis. Fine needle aspiration of the lump was suspicious for MFH with immunocytochemistry positive for CD68. With the interim diagnosis of recurrent left paratesticular soft tissue sarcoma, the patient underwent wide local excision of the mass with total scrotectomy and left high level orchidectomy. Grossly a large single, multilobulated and nodular solid grey white mass replacing nearly the whole left testis and paratesticular tissue and extending to the inguinal region up to the deep ring [Figure 1]. The mass had spared the root of the penis. Microscopically the tumor consisted of highly pleomorphic spindle tumor cells arranged in a storiform pattern with numerous multinucleated giant cells and frequent mitoses (mitotic count of approx 10-12/10 hpf) along with areas of necrosis (less than 50% tumor necrosis for all the examined tumor surface) [Figure 2], [Figure 3]. According to the French Federation of Cancer Sarcoma Group, the neoplasm was diagnosed grade III sarcoma. Immunohistochemistry staining with CD 68 [Figure 4] and did not react with S100, NF, actin, desmin, smooth muscle actin and myogenin. The patient was planned for adjuvant external beam radiotherapy to the locoregional area.
Figure 1: Represents the cut section of the orchidectomy specimen which shows the fleshy tumor infiltrating the testis and the adjacent scrotal skin

Click here to view
Figure 2: Represents microscopic picture of malignant fibrous histiocytoma with the marked pleomorphism from spindle cells to giant cells

Click here to view
Figure 3: Represents tumor cells displaced in a storiform pattern which is classically seen in malignant fibrous histiocytoma

Click here to view
Figure 4: Represents the CD68 positivity on immunohistochemistry which is a nonspecific marker of Malignant fibrous histiocytoma

Click here to view

Paratesticular sarcomas are an extremely rare entity and a paucity of information about their management exists in the literature. MFH is a highly aggressive tumor which commonly involves the extremities. MFH of the paratesticular region are much more rare malignancy with less than 43 reported cases till date.[1],[2] They usually arise from the testicular tunics or the spermatic cord.[3] Histopathologically is classified into four types: storiform-pleomorphic, myxoid, giant cell and inflammatory with storiform type being the most common. MFH may mimic the histopathologic appearance of other sarcomas, e.g., de-differentiated and pleomorphic liposarcoma, pleomorphic leiomyosarcoma. Pleomorphic sarcomas have a characteristically illdefined fascicular pattern, cellular and nuclear pleomorphism, bizarre tumor cells with frequent mitoses and necrosis. In this case the other sarcomas were ruled by the absence of any differentiation towards them (conventional/classical area of liposarcoma, leiomyosarcoma, rhabdomyosarcoma, nerve sheath tumor) in total examined tumor surface. The tumor showed similar morphology in all the areas and the specimen was extensively sampled. Still no area of adipocytic, smooth muscle, skeletal muscle or neural differentiation was seen. Moreover, negative immunohistochemical staining (S 100, NF, smooth muscle actin, desmin and myogenin) ruled out these sarcomas. MFH has no specific markers, but can show focal positivity for CD68, S100 and vimentin and is a diagnosis of exclusion.

MFH tends to recur locally thereby the treatment of choice is radical orchiectomy, with complete removal of all seminal cord structures. Ligation of the spermatic cord should be as high as possible. Despite complete resection, local recurrence has been reported to be 51%. Adjuvant locoregional (ipsilateral pelvic and groin nodes and scrotum) radiation reduces the risk of local recurrence.[4] Fagundes et al., reported no local recurrence in patients receiving adjuvant radiation, compared with 37% local failure in those treated with orchidectomy alone.[4] Modest activity with doxorubicin and dacarbazine based chemotherapy has been reported with MFH.[5],[6]

  Conclusion Top

Paratesticular MFH are uncommon tumors with a high tendency towards local recurrence. Despite the poor prognosis a prediction of the individual biological behavior of the locally recurrent tumor is difficult. Local wide excision and adjuvant radiochemotherapy might enable long-term survival in selected cases.

  References Top

Guo J, Zhou S, Rao NP, Pez GH. Pleomorphic malignant fibrous histiocytoma/undifferentiated high-grade pleomorphic sarcoma of the scrotum in a patient presenting as fournier gangrene: A case report. Appl Immunohistochem Mol Morphol 2010;18:473-8.  Back to cited text no. 1
Takezawa K, Matsuoka Y, Takao T, Nonomura N, Tomita Y, Okuyama A. Myxofibrosarcoma of the spermatic cord: A case report. Nihon Hinyokika Gakkai Zasshi 2008;99:555-9.  Back to cited text no. 2
Hedinger CE, Dhom G. Hodengeschwülste, Kapitel 6; In: Hedinger CE, Dhom G. editors. Pathologie des männlichen Genitale. Berlin: Springer; 1991. p. 409.  Back to cited text no. 3
Khoubehi B, Mishra V, Ali M, Motiwala H, Karim O. Adult paratesticular tumours. BJU Int 2002;90:707-15.  Back to cited text no. 4
Patel SR, Plager C, Papadopoulos NE, Benjamin RS. Myxoid malignant fibrous histiocytom: Experience with chemotherapy. Am J Clin Oncol 1995;18:528-31.  Back to cited text no. 5
Padula GD, Schmitz M. Adult paratesticular malignant fibrous histiocytoma treated with surgery, systemic chemotherapy and postoperative adjuvant radiotherapy. J Cancer Res Ther 2006;2:201-2.  Back to cited text no. 6


  [Figure 1], [Figure 2], [Figure 3], [Figure 4]

This article has been cited by
1 Radiation-Induced Sarcoma following Prolonged Coronary Stent Placement
Eric J. Vick,Christopher T. Clark,James M. Lewis
Case Reports in Surgery. 2018; 2018: 1
[Pubmed] | [DOI]


Print this article  Email this article


  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow